Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Feds ink COVID-19 vaccine distro deal with McKesson

By Sean Whooley | August 17, 2020

The U.S. Dept. of Health and Human Services (HHS) and Defense Dept. (DoD) announced a COVID-19 vaccine distribution deal with McKesson.

Under Operation Warp Speed, McKesson will become a central distributor of future COVID-19 vaccines and related supplies needed to administer the pandemic vaccinations, according to a news release.

The Centers for Disease Control and Prevention (CDC) is executing an existing contract option with McKesson to support the vaccine distribution, as the company already distributed H1N1 vaccines during the H1N1 pandemic that lasted from 2009 to 2010. The current contract includes an option for the distribution of vaccines in the event of a pandemic.

According to HHS and DoD, planning is underway to ensure rapid distribution once the FDA authorizes one or more vaccines, and McKesson will work under the CDC’s guidance to ship the vaccines to administration sites.

“Today’s announcement puts another building block in place as the Nation moves toward a safe and effective COVID-19 vaccine,” CDC Director Dr. Robert Redfield said in the release “America’s march toward one or more safe and effective COVID-19 vaccines is a combined effort between American industry and the federal government. McKesson is a leader in their field, and we welcome their expertise and dedication to public health.”

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

Cellares Logo (1)
Cellares raises $257M to industrialize cell therapy manufacturing
Antheia_Logo (1)
Antheia closes $80M financing to strengthen U.S. drug manufacturing
Apiject Logo
Apiject to open new injectable drug manufacturing facility in North Carolina
This is the logo of Novartis.
Novartis opens new manufacturing plant in California
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE